MTOR and neoplasm: Using a blood–brain barrier-penetrating liposomal system for CDX-modified liposomes (termed CDX-LIPO, and the non-modified liposomes termed LIPO), negative regulation of the mTOR pathway led to remarkable tumor cell death and simultaneous stimulation and activity of pro-tumor macrophages and T cells [41].